Vectibix for Colorectal Cancer User Reviews
Vectibix has an average rating of 6.3 out of 10 from a total of 3 reviews for the treatment of Colorectal Cancer. 67% of reviewers reported a positive experience, while 33% reported a negative experience.
- Glenn...
- March 29, 2016
"Its bad enough to have cancer, but this drug doesn't work and turns patients into lepers"
- Anonymous
- Taken for 1 to 6 months
- November 8, 2017
"This medication has my carcinoembryonic antigen (CEA) test numbers way down . I hate the rash but at least I'm alive."
- Anonymous
- Taken for 1 to 6 months
- December 27, 2017
"Have been on this 8-2017 and my CEA marker is down from 16.1 to 3.6. Side effect of dry skin is tolerable."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Colorectal Cancer
Care guides
Symptoms and treatments
Medicine.com guides (external)
More about Vectibix (panitumumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
"Vectibix reduced my CEA (cancer marker) from 25.2 all the way down to 2.5 within the matter of a few months. The skin reaction SUCKS. Thankfully Ia able to undergo a revolutionary surgery to remove the portion of my liver with the metastatic cancer so I have just recently been able to stop the Vectibix. I am hoping I will get my beautiful skin back."